Phase 2 Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Control Group (people without a stroke or spinal cord injury):
- Adults aged 18 or over
- People who have signed a consent form agreeing to take part
- People covered by the French social security system
Post-Stroke Group:
- Adults aged 18 or over who had a stroke more than 3 weeks ago
- People whose doctor considers them medically stable
- People who have signed a consent form agreeing to take part
- People covered by the French social security system
Spinal Cord Injury Group:
- Adults aged 18 or over with a complete or incomplete spinal cord injury (rated A through D on a standard injury scale called the ASIA Impairment Scale)
- People whose doctor considers them medically stable
- People with paralysis affecting all four limbs due to a neck-level spinal cord injury
- People who have signed a consent form agreeing to take part
- People covered by the French social security system
Who may not be able to join:
- People living with an ongoing long-term health condition
- People with skin problems or open wounds
- People with a history of epilepsy or seizures
- People with certain medical devices or conditions that make MRI or magnetic/electrical brain stimulation unsafe, including a heart pacemaker, an implanted hearing aid, metal fragments in the eye, a history of working with metal, a neurostimulator, or severe claustrophobia (fear of enclosed spaces)
- People with implanted medical devices — such as heart valves, vascular implants, brain shunts, surgical clips, metal stitches or staples, stents, or bone hardware — that have not been officially cleared as safe for MRI use under an international safety standard
- People who are legally under the care or protection of a guardian or court-appointed representative
- Women who are pregnant or breastfeeding
- People who do not wish to be told if an unexpected finding is discovered during their MRI scan
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Fabien Wagner, PhD, Institute of Neurodegenerative Diseases, CNRS UMR 5293
Phone: +33 5 33 51 48 46
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sensory Performance; Quantitative Prehension Performance
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.